Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kitzis

Showing results (51-60 of 275) with videos related to

Pageof 28
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 31, 2008
Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622Caroline Norez, Frédéric Bilan, Alain Kitzis, et al.
Pathologie-Biologie|January 1, 1982
[Bone penetration of cefazoline (author's transl)]J F Acar, M D Kitzis, J Evrard, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1989
Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibioticsF Nélet, L Gutmann, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1986
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamasesL Gutmann, M D Kitzis, S Yamabe, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1993
Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by EnterobacteriaceaeX Y Zhou, M D Kitzis, J F Acar, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocciM D Kitzis, F W Goldstein, N Ishida, et al.
Annales De Microbiologie|March 1, 1983
[Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus]M D Kitzis, F W Goldstein, R Labia, et al.
DNA and Cell Biology|April 8, 2004
The ink4a/arf locus evolution in primates: characterization of three ARF sequencesAnne Di Tommaso, Cédric Soler, Christian Roos, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalisM D Kitzis, F W Goldstein, M Miegi, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Activity of imipenem on aerobic bacteriaJ F Acar, F W Goldstein, M D Kitzis, et al.
Pageof 28

Showing results (51-60 of 275) with videos related to

Sort By:
Pageof 28
The Journal of Pharmacology and Experimental Therapeutics|January 31, 2008
Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622Caroline Norez, Frédéric Bilan, Alain Kitzis, et al.
Pathologie-Biologie|January 1, 1982
[Bone penetration of cefazoline (author's transl)]J F Acar, M D Kitzis, J Evrard, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1989
Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibioticsF Nélet, L Gutmann, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1986
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamasesL Gutmann, M D Kitzis, S Yamabe, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1993
Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by EnterobacteriaceaeX Y Zhou, M D Kitzis, J F Acar, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocciM D Kitzis, F W Goldstein, N Ishida, et al.
Annales De Microbiologie|March 1, 1983
[Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus]M D Kitzis, F W Goldstein, R Labia, et al.
DNA and Cell Biology|April 8, 2004
The ink4a/arf locus evolution in primates: characterization of three ARF sequencesAnne Di Tommaso, Cédric Soler, Christian Roos, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalisM D Kitzis, F W Goldstein, M Miegi, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Activity of imipenem on aerobic bacteriaJ F Acar, F W Goldstein, M D Kitzis, et al.
Pageof 28